MedPath

The effect of oral zinc administered on the bilirubin serum level in the icteric mature newborns

Phase 1
Conditions
Hyperbilirubinemia.
Physiological jaundice (intense)(prolonged) NOS
Registration Number
IRCT2016072629077N1
Lead Sponsor
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Full term newborns; with of age for more than 72 hours & serum bilirubin level more than 15 mg/dl.
Exclusion criteria: All babies who received medication such as zinc sulphate & phenobarbital by mothers or newborn

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum bilirubin's level. Timepoint: Total serum bilirubin level at the time of admission, daily during the hospitalization and at the time of the discharge. Method of measurement: Measuring of the total serum bilirubin level by biochemistry kits manufactured in Iran and by the method of spectrophotometry.
Secondary Outcome Measures
NameTimeMethod
Serum zinc's level. Timepoint: At the time of admission and discharge. Method of measurement: Auto analyser.
© Copyright 2025. All Rights Reserved by MedPath